🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Professor Anthony Gordon, REMAP-CAP's UK Chief Investigator, has been awarded an MBE (Member of the Order of the British Empire) for his contribution to #criticalcare. Congratulations on this important recognition, Anthony Gordon 👏 imperial.nhs.uk/about-us/news/… Imperial College London

Those working on the REMAP-CAP trial in Europe are eligible for an attendance grant from Ecraid. Follow the link below for details on how to apply 👇

There was a lot of discussion around the presentation of the remap-cap steroids for non-COVID community-acquired pneumonia domain results at #CCR24 Steve Webb from ANZICS Clinical Trials Group & Scott Berry from Berry Consultants discuss their findings The data are presently unpublished

▶️ Module 4 is out! It introduces 2 adaptive randomisation designs + 3 case studies: I-SPY 2, remap-cap & ATTACC CAP. Read about the content & speakers 👉🏾 mailchi.mp/ecraid/watch-m… Access the module for free 👉🏼 channel.ersnet.org/media-106923-e…

Attending the #ERSCongress2024? Join this postgrad course to hear @Lennie333 discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇 ERS UMC Utrecht International Infection & Immunity UMC Utrecht European Commission

🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally. A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼 #10YearsREMAPCAP

🇵🇰 Ziauddin University is one of 7 sites in Pakistan currently participating in REMAP-CAP. Its Patient and Public Involvement & Engagement group recently produced a great video explaining #clinicaltrials in Urdu and with locally relevant graphics. Check it out 👉 youtube.com/watch?v=dCZqm6…

Belgrade University Tel Aviv University, Karolinska Institutet, Charles University UMC Utrecht International Infection & Immunity UMC Utrecht Universität Freiburg Amsterdam UMC Aarhus University ESCMID

Thrilled to have @RienkPypstra from our COMBACTE-CARE days, visit and share his insights on Ecraid's role in #infectiousdiseases research. We're committed to being a hub for clinical trials, data management, real-world evidence & #outbreakresponse. @tranScripLtd #PublicHealth

Thank you to our fantastic ICU team on #Red4Research day for their ongoing support with Clinical Trials AIRWAYS-3 ABBRUPT Trial GenOMICC Study iRehabTrial remap-cap ❤️

🚨 Last chance to register for the Ecraid x ESCMID Better Methods postgrad course. Sharpen your tools with the help of top experts like Marc Bonten. Read more 👉🏾 lnkd.in/esWshVsU 📅  22-24 October 2024 📍  Belgrade, Serbia ⏳  Registration closes 4 October

REMAP-CAP team members attended the Federated Platform Trials meeting in Dublin organised by Irish Critical Care Clinical Trials Network, ISARIC & InFACT. The focus was on principles to enable platform #clinicaltrials to federate effectively, particularly in the field of #criticalcare.

▶️ Learn about platform #clinicaltrials in Module 5 of our Adaptive #ClinicalTrial Designs series! ➕ PRACTical design & RECOVERY, remap-cap & NeoSep1 trials With the brilliant Pavel Mozgunov @thomas_jaki @Lennie333 Sarah Walker & Julia Bielicki Read more 👉🏼ecraid.eu/news/watch-mod…

Our friends at the Dutch hospital UMC Utrecht International highlight REMAP-CAP's exceptional contribution to tackling community-acquired #pneumonia & #COVID19 🫁 Read the article 👉 research.umcutrecht.nl/stories/remap-… #10YearsREMAPCAP @Lennie333 Marc Bonten Infection & Immunity UMC Utrecht

What does being a pragmatic trial mean in South Asia? We evaluated 3 international trials (remap-cap Mega-ROX RECOVERY) Absent post-discharge follow up and poor physician and public understanding of trials constrained their incorporation into usual care

Empowering Patients - Revising Informed Consent Processes for Critical Care Trials in Pakistan Our public group has worked with us to make informed consent for Mega-ROX and remap-cap more culturally sensitive and relevant in the Pakistani context

Keeping patients, their families and the public engaged is a strength of REMAP-CAP. 🇵🇰 The Pakistani Patient & Public Involvement & Engagement group's 2024 summit gained national news coverage and presented networking opportunities. 👉 youtube.com/watch?v=3Lsged… #10YearsREMAPCAP

🫁 Today we mark #WorldPneumoniaDay2024. The #remapcapfamily has been tackling community-acquired #pneumonia for a decade now, and our joint efforts have positively impacted many lives around the world. #10YearsREMAPCAP #infectiousdiseases #clinicalresearch #covid19

REMAP-CAP expanded immensely during the #COVID19 #pandemic, but in many regions it predates that period. 🇯🇵 开云开云体育百家乐乐鱼体育开云百家乐开云体育百家乐开云九游电子棋牌彩票电竞真人六合彩 Japan commenced in 2020 & has had an outsized impact on #clinicalresearch in the country, paving the way for other adaptive platform trials. #10YearsREMAPCAP

REMAP-CAP's Lennie Derde adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇